Assistant Professor
Johns Hopkins University
Baltimore, MD, United States
Dr. Kaitlyn Frazier is a head and neck endocrine surgeon at Johns Hopkins School of Medicine, specializing in the treatment of benign and malignant diseases of the thyroid and parathyroid glands. She offers patients a range of surgical options, including traditional open surgeries as well as transoral or “scarless” thyroid surgery and nonsurgical ablation of thyroid nodules. She also treats advanced thyroid cancers as part of a multidisciplinary team that includes endocrinologists, airway surgeons, head and neck reconstructive surgeons, and speech-language pathologists. She earned her medical degree from the Emory University School of Medicine and completed residency training in otolaryngology–head and neck surgery at Johns Hopkins, where she remained for advanced fellowship training in head and neck endocrine surgery. Prior to her clinical training, Dr. Frazier studied biomedical engineering at the Georgia Institute of Technology and spent several years in management consulting at Bain & Company with a focus on organizational strategy/design and market research. Dr. Frazier’s research interests include clinical and quality of life outcomes for radiofrequency and microwave ablation of benign thyroid nodules, radiofrequency ablation of thyroid microcarcinomas, remote access surgery, intraoperative technology adjuncts, and advanced therapies for thyroid cancer. She also draws upon her consulting background with the use of analytics to inform parameters for clinical best practices and guidelines, as well as for quality and safety initiatives, including leading a multidisciplinary hospital-wide risk assessment on clinical communications tools. She is an active member of the American Thyroid Association, the Endocrine Surgery Section of the American Head and Neck Society, the North American Society for Interventional Thyroidology, and the American Academy of Otolaryngology–Head and Neck Surgery.
Disclosure information not submitted.
Thermal Ablation - A Game Changer in the Management of Benign and Malignant Thyroid nódules
Saturday, October 11, 2025
2:30 PM - 3:30 PM EDT
Evolving Challenges in Clinical Communication: Balancing Patient Expectations, Safety, and Burnout
Saturday, October 11, 2025
4:00 PM - 5:00 PM EDT
Primary Hyperparathyroidism: Work Up to Surgical Approach - Multinational Perspective
Monday, October 13, 2025
1:00 PM - 2:00 PM EDT